KCTD5 and morphine dependence: To further validate the role of KCTD5/CUL3 in AC sensitization of PVT in morphine dependence, 2 to 3 weeks after local injection of CUL3 shRNA-expressing AAV, the mice were exposed to escalating dose of morphine (Fig 7A and 7B).